Hematological Diseases and Therapies

Welcome to "Hematological Diseases and Therapies," a peer-reviewed, open-access journal dedicated to advancing knowledge and understanding in the field of hematological diseases and their therapeutic interventions. Our journal serves as a platform for researchers, clinicians, and healthcare professionals to share groundbreaking discoveries, innovative therapies, and insightful perspectives that contribute to the progress of hematology.

Mission

Our mission is to foster collaboration and dissemination of high-quality research focused on hematological diseases and their management. We strive to provide a comprehensive and accessible resource for the global scientific community, promoting advancements in both basic and clinical research.

Scope

"Hematological Diseases and Therapies" covers a broad spectrum of topics within the field of hematology, including but not limited to:

• Blood Disorders: Exploration of various blood disorders, such as anemia, leukemia, lymphoma, and coagulation disorders.

• Diagnostic Techniques: Development and refinement of diagnostic tools and techniques for accurate and timely identification of hematological diseases.

• Therapeutic Strategies: Evaluation of novel therapeutic approaches, including pharmacological interventions, stem cell therapies, and immunotherapies.

• Translational Research: Bridging the gap between basic science and clinical applications to improve patient outcomes.

• Epidemiology and Public Health: Understanding the prevalence, distribution, and impact of hematological diseases on populations, as well as strategies for prevention and public health interventions.

Read More At Aims and Scope Page

Editorial Board

Our journal is supported by a distinguished international editorial board comprising experts in hematology, oncology, immunology, and related disciplines. The editorial team is committed to maintaining the highest standards of scientific integrity and ensuring a rigorous peer-review process.

Submission Guidelines

We invite researchers and clinicians to submit their original research articles, reviews, case studies, case reports, and perspectives for consideration. Detailed submission guidelines can be found on our website.

Open Access Policy

"Hematological Diseases and Therapies" is an open-access journal, meaning that all content is freely available to the global scientific community. This open-access model facilitates the rapid dissemination of knowledge, promoting collaboration and accelerating the pace of discovery in hematology.

Peer Review Process

At "Hematological Diseases and Therapies," we uphold a stringent peer-review process to guarantee the excellence and credibility of published research. A team of proficient reviewers, drawn from our esteemed editorial board, meticulously assesses submissions for scientific rigor, originality, methodological robustness, and relevance to the field of hematological diseases. This commitment ensures that only high-quality, impactful research contributes to the advancement of knowledge in hematology within the pages of our journal.

Indexing & Abstracting

All published articles are assigned to Digital Object Identifier (DOI) - Crossref.

All published articles of this journal are included in the indexing and abstracting coverage of:

• Scilit
• ResearchGate
• Google Scholar
• ScienceGate
• Semantic Scholars
• ACADEMIA
• Dimensions AI
• FatCat Wiki
• Internet Archive Scholar
• Directory of Open Access Scholarly Resources
• CrossRef
• Genamics – JournalSeek
• Academic Keys
• ResearchBib - Academic Research Index
• Geneva Foundation for Medical Education and Research
• International Innovative Journal Impact Factor (IIJIF)
• Open J-Gate
• Directory of Journals indexing

All published articles are permanently archived and available at Gavin Publishers website in HTML and PDF formats.

Contact Information

For inquiries, submissions, and other correspondence, please contact the editorial office at

contact@gavinpublishers.org

We invite researchers, clinicians, and scholars to explore, contribute, and engage with "Hematological Diseases and Therapies" as we work together to advance our understanding of hematological diseases and improve patient care.